TOCILIZUMAB
Source | S100 HSD Public |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
10056GMP | TOCILIZUMAB tocilizumab 200 mg/10 mL injection, 10 mL vial (PI, CMI) |
1 | 1 | 0 | $203.73 | $31.60 | $31.60 |
Available brands | |||||||
Actemra |
TOCILIZUMAB
Source | S100 HSD Private |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
10060LMP | TOCILIZUMAB tocilizumab 400 mg/20 mL injection, 20 mL vial (PI, CMI) |
1 | 1 | 0 | $430.28 | $31.60 | $31.60 |
Available brands | |||||||
Actemra |
TOCILIZUMAB
Source | S100 HSD Public |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
10064QMP | TOCILIZUMAB tocilizumab 400 mg/20 mL injection, 20 mL vial (PI, CMI) |
1 | 1 | 0 | $405.39 | $31.60 | $31.60 |
Available brands | |||||||
Actemra |
TOCILIZUMAB
Source | S100 HSD Private |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
10068XMP | TOCILIZUMAB tocilizumab 80 mg/4 mL injection, 4 mL vial (PI, CMI) |
1 | 1 | 0 | $94.86 | $31.60 | $31.60 |
Available brands | |||||||
Actemra |
TOCILIZUMAB
Source | S100 HSD Public |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
10077JMP | TOCILIZUMAB tocilizumab 80 mg/4 mL injection, 4 mL vial (PI, CMI) |
1 | 1 | 0 | $82.19 | $31.60 | $31.60 |
Available brands | |||||||
Actemra |
TOCILIZUMAB
Source | S100 HSD Private |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
10079LMP | TOCILIZUMAB tocilizumab 200 mg/10 mL injection, 10 mL vial (PI, CMI) |
1 | 1 | 0 | $220.55 | $31.60 | $31.60 |
Available brands | |||||||
Actemra |
TOCILIZUMAB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
11720WMP | TOCILIZUMAB tocilizumab 162 mg/0.9 mL injection, 4 x 0.9 mL syringes (PI, CMI) |
1 | 4 | 2 | $813.27 | $31.60 | $31.60 |
Available brands | |||||||
Actemra Subcutaneous Injection |
TOCILIZUMAB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
11734NMP | TOCILIZUMAB tocilizumab 162 mg/0.9 mL injection, 4 x 0.9 mL pen devices (PI, CMI) |
1 | 4 | 1 | $813.27 | $31.60 | $31.60 |
Available brands | |||||||
Actemra ACTPen |
TOCILIZUMAB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
11742BMP | TOCILIZUMAB tocilizumab 162 mg/0.9 mL injection, 4 x 0.9 mL pen devices (PI, CMI) |
1 | 4 | 2 | $813.27 | $31.60 | $31.60 |
Available brands | |||||||
Actemra ACTPen |
TOCILIZUMAB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
11748HMP | TOCILIZUMAB tocilizumab 162 mg/0.9 mL injection, 4 x 0.9 mL syringes (PI, CMI) |
1 | 4 | 1 | $813.27 | $31.60 | $31.60 |
Available brands | |||||||
Actemra Subcutaneous Injection |
ADALIMUMAB
Source | S100 HSD Public |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
12348XMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (PI, CMI) |
1 | 2 | 5 | $505.95 | $31.60 | $31.60 |
Available brands | |||||||
Abriladaa | |||||||
Amgevitaa | |||||||
Hadlimaa | |||||||
Hyrimoza |
ADALIMUMAB
Source | S100 HSD Private |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
12349YMP | ADALIMUMAB adalimumab 20 mg/0.4 mL injection, 0.4 mL syringe (PI, CMI) |
2 | 2 | 5 | $652.33 | $31.60 | $31.60 |
Available brands | |||||||
Amgevitaa |
ADALIMUMAB
Source | S100 HSD Public |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
12355GMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 5 | $505.95 | $31.60 | $31.60 |
Available brands | |||||||
Abriladaa | |||||||
Amgevitaa | |||||||
Hadlimaa | |||||||
Hyrimoza |
ADALIMUMAB
Source | S100 HSD Private |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
12368YMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 5 | $534.86 | $31.60 | $31.60 |
Available brands | |||||||
Abriladaa | |||||||
Amgevitaa | |||||||
Hadlimaa | |||||||
Hyrimoza |
ADALIMUMAB
Source | S100 HSD Private |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
12384TMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (PI, CMI) |
1 | 2 | 5 | $534.86 | $31.60 | $31.60 |
Available brands | |||||||
Abriladaa | |||||||
Amgevitaa | |||||||
Hadlimaa | |||||||
Hyrimoza |
ADALIMUMAB
Source | S100 HSD Public |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
12417MMP | ADALIMUMAB adalimumab 20 mg/0.4 mL injection, 0.4 mL syringe (PI, CMI) |
2 | 2 | 5 | $618.90 | $31.60 | $31.60 |
Available brands | |||||||
Amgevitaa |
ADALIMUMAB
Source | S100 HSD Private |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
13210GMP | ADALIMUMAB adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes (PI, CMI) |
1 | 2 | 5 | $534.86 | $31.60 | $31.60 |
Available brands | |||||||
Adalicipa | |||||||
Hadlimaa | |||||||
Humiraa | |||||||
Yuflymaa |
ADALIMUMAB
Source | S100 HSD Public |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
13212JMP | ADALIMUMAB adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices (PI, CMI) |
1 | 2 | 5 | $505.95 | $31.60 | $31.60 |
Available brands | |||||||
Adalicipa | |||||||
Hadlimaa | |||||||
Humiraa | |||||||
Hyrimoza | |||||||
Yuflymaa |
ADALIMUMAB
Source | S100 HSD Public |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
13228FMP | ADALIMUMAB adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes (PI, CMI) |
1 | 2 | 5 | $505.95 | $31.60 | $31.60 |
Available brands | |||||||
Adalicipa | |||||||
Hadlimaa | |||||||
Humiraa | |||||||
Yuflymaa |
ADALIMUMAB
Source | S100 HSD Private |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
13229GMP | ADALIMUMAB adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices (PI, CMI) |
1 | 2 | 5 | $534.86 | $31.60 | $31.60 |
Available brands | |||||||
Adalicipa | |||||||
Hadlimaa | |||||||
Humiraa | |||||||
Hyrimoza | |||||||
Yuflymaa |
ADALIMUMAB
Source | S100 HSD Private |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
13292NMP | ADALIMUMAB adalimumab 20 mg/0.2 mL injection, 2 x 0.2 mL syringes (PI, CMI) |
1 | 2 | 5 | $598.79 | $31.60 | $31.60 |
Available brands | |||||||
Humiraa |
ADALIMUMAB
Source | S100 HSD Public |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
13293PMP | ADALIMUMAB adalimumab 20 mg/0.2 mL injection, 2 x 0.2 mL syringes (PI, CMI) |
1 | 2 | 5 | $567.42 | $31.60 | $31.60 |
Available brands | |||||||
Humiraa |
ETANERCEPT
Source | S100 HSD Public |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
13294QMP | ETANERCEPT etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (PI, CMI) |
2 | 2 | 5 | $743.62 | $31.60 | $31.60 |
Available brands | |||||||
Enbrel |
ETANERCEPT
Source | S100 HSD Private |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
13295RMP | ETANERCEPT etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (PI, CMI) |
2 | 2 | 5 | $782.03 | $31.60 | $31.60 |
Available brands | |||||||
Enbrel |
TOCILIZUMAB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
13301CMP | TOCILIZUMAB tocilizumab 162 mg/0.9 mL injection, 4 x 0.9 mL syringes (PI, CMI) |
1 | 4 | 2 | $813.27 | $31.60 | $31.60 |
Available brands | |||||||
Actemra Subcutaneous Injection |
TOCILIZUMAB
Source | S100 HSD Public |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
13305GMP | TOCILIZUMAB tocilizumab 200 mg/10 mL injection, 10 mL vial (PI, CMI) |
1 | 1 | 5 | $203.73 | $31.60 | $31.60 |
Available brands | |||||||
Actemra |
TOCILIZUMAB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
13306HMP | TOCILIZUMAB tocilizumab 162 mg/0.9 mL injection, 4 x 0.9 mL pen devices (PI, CMI) |
1 | 4 | 2 | $813.27 | $31.60 | $31.60 |
Available brands | |||||||
Actemra ACTPen |
ETANERCEPT
Source | S100 HSD Public |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
13308KMP | ETANERCEPT etanercept 50 mg/mL injection, 4 x 1 mL syringes (PI, CMI) |
1 | 1 | 5 | $743.60 | $31.60 | $31.60 |
Available brands | |||||||
Enbrela |
TOCILIZUMAB
Source | S100 HSD Private |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
13311NMP | TOCILIZUMAB tocilizumab 80 mg/4 mL injection, 4 mL vial (PI, CMI) |
2 | 2 | 5 | $179.63 | $31.60 | $31.60 |
Available brands | |||||||
Actemra |
TOCILIZUMAB
Source | S100 HSD Private |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
13312PMP | TOCILIZUMAB tocilizumab 200 mg/10 mL injection, 10 mL vial (PI, CMI) |
1 | 1 | 5 | $220.55 | $31.60 | $31.60 |
Available brands | |||||||
Actemra |
ETANERCEPT
Source | S100 HSD Public |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
13319BMP | ETANERCEPT etanercept 50 mg/mL injection, 4 x 1 mL pen devices (PI, CMI) |
1 | 1 | 5 | $743.60 | $31.60 | $31.60 |
Available brands | |||||||
Enbrela |
TOCILIZUMAB
Source | S100 HSD Public |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
13324GMP | TOCILIZUMAB tocilizumab 80 mg/4 mL injection, 4 mL vial (PI, CMI) |
2 | 2 | 5 | $164.38 | $31.60 | $31.60 |
Available brands | |||||||
Actemra |
ETANERCEPT
Source | S100 HSD Private |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
13326JMP | ETANERCEPT etanercept 50 mg/mL injection, 4 x 1 mL pen devices (PI, CMI) |
1 | 1 | 5 | $782.01 | $31.60 | $31.60 |
Available brands | |||||||
Enbrela |
ETANERCEPT
Source | S100 HSD Private |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
13332QMP | ETANERCEPT etanercept 50 mg/mL injection, 4 x 1 mL syringes (PI, CMI) |
1 | 1 | 5 | $782.01 | $31.60 | $31.60 |
Available brands | |||||||
Enbrela |
TOCILIZUMAB
Source | S100 HSD Private |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
13338BMP | TOCILIZUMAB tocilizumab 400 mg/20 mL injection, 20 mL vial (PI, CMI) |
1 | 1 | 5 | $430.28 | $31.60 | $31.60 |
Available brands | |||||||
Actemra |
TOCILIZUMAB
Source | S100 HSD Public |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
13339CMP | TOCILIZUMAB tocilizumab 400 mg/20 mL injection, 20 mL vial (PI, CMI) |
1 | 1 | 5 | $405.39 | $31.60 | $31.60 |
Available brands | |||||||
Actemra |
TOFACITINIB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
13737BMP | TOFACITINIB tofacitinib 5 mg tablet, 56 (PI, CMI) |
1 | 56 | 5 | $1212.40 | $31.60 | $31.60 |
Available brands | |||||||
Xeljanz |
TOFACITINIB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
13738CMP | TOFACITINIB tofacitinib 1 mg/mL oral liquid, 240 mL (PI, CMI) |
1 | 1 | 5 | $1212.40 | $31.60 | $31.60 |
Available brands | |||||||
Xeljanz |
TOFACITINIB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
13755YMP | TOFACITINIB tofacitinib 5 mg tablet, 56 (PI, CMI) |
1 | 56 | 3 | $1212.40 | $31.60 | $31.60 |
Available brands | |||||||
Xeljanz |
TOFACITINIB
SO
Products that are in a Supply Only state will be available for dispensing, but not
for prescribing. PBS Prescriptions written prior to the Supply Only period are able
to be dispensed using either the Supply Only product where available, or an equivalent
product as specified on the PBS schedule.
Supply only until 01/01/2026
Products that are in a Supply Only state will be available for dispensing, but not
for prescribing. PBS Prescriptions written prior to the Supply Only period are able
to be dispensed using either the Supply Only product where available, or an equivalent
product as specified on the PBS schedule.
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
13757CMP | TOFACITINIB tofacitinib 5 mg tablet, 56 (PI, CMI) |
1 | 56 | 5 | $1212.40 | $31.60 | $31.60 |
Available brands | |||||||
Xeljanz
SO
Products that are in a Supply Only state will be available for dispensing, but not
for prescribing. PBS Prescriptions written prior to the Supply Only period are able
to be dispensed using either the Supply Only product where available, or an equivalent
product as specified on the PBS schedule.
|
TOFACITINIB
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
13770RMP | TOFACITINIB tofacitinib 1 mg/mL oral liquid, 240 mL (PI, CMI) |
1 | 1 | 3 | $1212.40 | $31.60 | $31.60 |
Available brands | |||||||
Xeljanz |
TOFACITINIB
SO
Products that are in a Supply Only state will be available for dispensing, but not
for prescribing. PBS Prescriptions written prior to the Supply Only period are able
to be dispensed using either the Supply Only product where available, or an equivalent
product as specified on the PBS schedule.
Supply only until 01/01/2026
Products that are in a Supply Only state will be available for dispensing, but not
for prescribing. PBS Prescriptions written prior to the Supply Only period are able
to be dispensed using either the Supply Only product where available, or an equivalent
product as specified on the PBS schedule.
Source | General Schedule |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
13776CMP | TOFACITINIB tofacitinib 1 mg/mL oral liquid, 240 mL (PI, CMI) |
1 | 1 | 5 | $1212.40 | $31.60 | $31.60 |
Available brands | |||||||
Xeljanz
SO
Products that are in a Supply Only state will be available for dispensing, but not
for prescribing. PBS Prescriptions written prior to the Supply Only period are able
to be dispensed using either the Supply Only product where available, or an equivalent
product as specified on the PBS schedule.
|
ETANERCEPT
Source | S100 HSD Public |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
5733RMP | ETANERCEPT etanercept 50 mg/mL injection, 4 x 1 mL syringes (PI, CMI) |
1 | 1 | 0 | $743.60 | $31.60 | $31.60 |
Available brands | |||||||
Enbrela |
ETANERCEPT
Source | S100 HSD Public |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
5734TMP | ETANERCEPT etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (PI, CMI) |
1 | 1 | 0 | $371.81 | $31.60 | $31.60 |
Available brands | |||||||
Enbrel |
ETANERCEPT
Source | S100 HSD Public |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
5735WMP | ETANERCEPT etanercept 50 mg/mL injection, 4 x 1 mL pen devices (PI, CMI) |
1 | 1 | 0 | $743.60 | $31.60 | $31.60 |
Available brands | |||||||
Enbrela |
ETANERCEPT
Source | S100 HSD Private |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
6367DMP | ETANERCEPT etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (PI, CMI) |
1 | 1 | 0 | $395.35 | $31.60 | $31.60 |
Available brands | |||||||
Enbrel |
ETANERCEPT
Source | S100 HSD Private |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
9615CMP | ETANERCEPT etanercept 50 mg/mL injection, 4 x 1 mL syringes (PI, CMI) |
1 | 1 | 0 | $782.01 | $31.60 | $31.60 |
Available brands | |||||||
Enbrela |
ETANERCEPT
Source | S100 HSD Private |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
9641KMP | ETANERCEPT etanercept 50 mg/mL injection, 4 x 1 mL pen devices (PI, CMI) |
1 | 1 | 0 | $782.01 | $31.60 | $31.60 |
Available brands | |||||||
Enbrela |
ADALIMUMAB
Source | S100 HSD Public |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
9662MMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (PI, CMI) |
1 | 2 | 0 | $505.95 | $31.60 | $31.60 |
Available brands | |||||||
Abriladaa | |||||||
Amgevitaa | |||||||
Hadlimaa | |||||||
Hyrimoza |
ADALIMUMAB
Source | S100 HSD Public |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
9663NMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 0 | $505.95 | $31.60 | $31.60 |
Available brands | |||||||
Abriladaa | |||||||
Amgevitaa | |||||||
Hadlimaa | |||||||
Hyrimoza |
ADALIMUMAB
Source | S100 HSD Private |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
9679KMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes (PI, CMI) |
1 | 2 | 0 | $534.86 | $31.60 | $31.60 |
Available brands | |||||||
Abriladaa | |||||||
Amgevitaa | |||||||
Hadlimaa | |||||||
Hyrimoza |
ADALIMUMAB
Source | S100 HSD Private |
Body System | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > IMMUNOSUPPRESSANTS > IMMUNOSUPPRESSANTS |
|
|
Code & Prescriber |
Medicinal Product Pack (Name, form & strength and pack size) |
Max qty packs | Max qty units | No. of repeats | DPMQ | Max Safety Net | General Patient Charge |
---|---|---|---|---|---|---|---|
9680LMP | ADALIMUMAB adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices (PI, CMI) |
1 | 2 | 0 | $534.86 | $31.60 | $31.60 |
Available brands | |||||||
Abriladaa | |||||||
Amgevitaa | |||||||
Hadlimaa | |||||||
Hyrimoza |
- Legend
- aBrand equivalent a
- MPMedical Practitioner
-
SO
Products that are in a Supply Only state will be available for dispensing, but not for prescribing. PBS Prescriptions written prior to the Supply Only period are able to be dispensed using either the Supply Only product where available, or an equivalent product as specified on the PBS schedule.